2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne

C99H131N30O37P6Si+ — CID 167700252

About 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne

2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne (PubChem CID 167700252) has the molecular formula C99H131N30O37P6Si+ and a molecular weight of 2547.24 g/mol. Its IUPAC name is 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne.

Molecular Properties

• Compound Name: 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne
• PubChem CID: 167700252
• Molecular Formula: C99H131N30O37P6Si+
• Molecular Weight: 2547.24 g/mol
• Exact Mass: 2545.75
• IUPAC Name: 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne
• SMILES: C.C.C#CC.Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(C)[C@H](n5cnc6c(NC(=O)c7ccccc7)ncnc65)O[C@@H]4COP(=O)(N4CCOCC4)OC2[C@H]3O[Si](C)(C)C(C)(C)C)c(=O)[nH]1.Cc1nc2c(ncn2[C@@H]2O[C@H](COP(C)(=O)O[C@@H]3C(C)[C@H](n4cnc5c(NC(=O)c6ccccc6)ncnc54)O[C@@H]3CO)[C@H](C)C2O[P+](=O)O)c(=O)[nH]1.Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(O)[C@H](n5cnc6c(N)ncnc65)O[C@@H]4COP(=O)(N4CCOCC4)OC2[C@H]3O)c(=O)[nH]1
• InChI: InChI=1S/C39H52N10O13P2Si.C31H35N9O11P2.C24H31N11O13P2.C3H4.2CH4/c1-22-29-25(58-37(22)48-20-42-27-32(40-19-41-33(27)48)46-35(50)24-11-9-8-10-12-24)17-56-63(52,47-13-15-55-16-14-47)60-31-30(62-65(6,7)39(3,4)5)26(18-57-64(53,54)61-29)59-38(31)49-21-43-28-34(49)44-23(2)45-36(28)51;1-15-20(49-31(24(15)50-52(44)45)40-14-35-22-27(40)36-17(3)37-29(22)43)11-47-53(4,46)51-23-16(2)30(48-19(23)10-41)39-13-34-21-25(32-12-33-26(21)39)38-28(42)18-8-6-5-7-9-18;25-18-12-19(28-7-27-18)34(8-29-12)22-15(37)16-11(46-22)6-43-49(39,33-1-3-42-4-2-33)47-17-14(36)10(5-44-50(40,41)48-16)45-23(17)35-9-30-13-20(35)31-24(26)32-21(13)38;1-3-2;;/h8-12,19-22,25-26,29-31,37-38H,13-18H2,1-7H3,(H,53,54)(H,44,45,51)(H,40,41,46,50);5-9,12-16,19-20,23-24,30-31,41H,10-11H2,1-4H3,(H2-,32,33,36,37,38,42,43,44,45);7-11,14-17,22-23,36-37H,1-6H2,(H,40,41)(H2,25,27,28)(H3,26,31,32,38);1H,2H3;2*1H4/p+1/t22?,25-,26-,29-,30+,31?,37-,38-,63?;15-,16?,19+,20+,23+,24?,30+,31+,53?;10-,11-,14+,15?,16+,17?,22-,23-,49?;;;/m101.../s1
• InChIKey: DBLSKXGLQBNXDA-CIAANCMPSA-O
• XLogP: 7.45
• TPSA: 846.63 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 57
• Rotatable Bonds: 22
• Heavy Atoms: 173
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2547.24
LogP ≤ 5	7.45
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	57

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne?

The IUPAC name of 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne (CID 167700252) is 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne.

What is the SMILES notation for 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne?

The canonical SMILES for 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne is C.C.C#CC.Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(C)[C@H](n5cnc6c(NC(=O)c7ccccc7)ncnc65)O[C@@H]4COP(=O)(N4CCOCC4)OC2[C@H]3O[Si](C)(C)C(C)(C)C)c(=O)[nH]1.Cc1nc2c(ncn2[C@@H]2O[C@H](COP(C)(=O)O[C@@H]3C(C)[C@H](n4cnc5c(NC(=O)c6ccccc6)ncnc54)O[C@@H]3CO)[C@H](C)C2O[P+](=O)O)c(=O)[nH]1.Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(O)[C@H](n5cnc6c(N)ncnc65)O[C@@H]4COP(=O)(N4CCOCC4)OC2[C@H]3O)c(=O)[nH]1.

What is the InChIKey of 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne?

The InChIKey is DBLSKXGLQBNXDA-CIAANCMPSA-O. The full InChI is InChI=1S/C39H52N10O13P2Si.C31H35N9O11P2.C24H31N11O13P2.C3H4.2CH4/c1-22-29-25(58-37(22)48-20-42-27-32(40-19-41-33(27)48)46-35(50)24-11-9-8-10-12-24)17-56-63(52,47-13-15-55-16-14-47)60-31-30(62-65(6,7)39(3,4)5)26(18-57-64(53,54)61-29)59-38(31)49-21-43-28-34(49)44-23(2)45-36(28)51;1-15-20(49-31(24(15)50-52(44)45)40-14-35-22-27(40)36-17(3)37-29(22)43)11-47-53(4,46)51-23-16(2)30(48-19(23)10-41)39-13-34-21-25(32-12-33-26(21)39)38-28(42)18-8-6-5-7-9-18;25-18-12-19(28-7-27-18)34(8-29-12)22-15(37)16-11(46-22)6-43-49(39,33-1-3-42-4-2-33)47-17-14(36)10(5-44-50(40,41)48-16)45-23(17)35-9-30-13-20(35)31-24(26)32-21(13)38;1-3-2;;/h8-12,19-22,25-26,29-31,37-38H,13-18H2,1-7H3,(H,53,54)(H,44,45,51)(H,40,41,46,50);5-9,12-16,19-20,23-24,30-31,41H,10-11H2,1-4H3,(H2-,32,33,36,37,38,42,43,44,45);7-11,14-17,22-23,36-37H,1-6H2,(H,40,41)(H2,25,27,28)(H3,26,31,32,38);1H,2H3;2*1H4/p+1/t22?,25-,26-,29-,30+,31?,37-,38-,63?;15-,16?,19+,20+,23+,24?,30+,31+,53?;10-,11-,14+,15?,16+,17?,22-,23-,49?;;;/m101.../s1.

What are the key properties of 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne?

2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne has a molecular weight of 2547.24 g/mol, XLogP of 7.45, 22 rotatable bonds, 13 hydrogen bond donors, and 57 hydrogen bond acceptors.

Where does this data come from?

All data for 2-amino-9-[(6R,8R,10R,15R,17R,18S)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one;[(2R,4S,5S)-5-[[[(2R,3R,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)-4-methyloxolan-3-yl]oxy-methylphosphoryl]oxymethyl]-4-methyl-2-(2-methyl-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-hydroxy-oxophosphanium;N-[9-[(6R,8R,10R,15R,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-12-hydroxy-9-methyl-17-(2-methyl-6-oxo-1H-purin-9-yl)-3-morpholin-4-yl-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-8-yl]purin-6-yl]benzamide;methane;prop-1-yne is sourced from PubChem (CID 167700252), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).